Sorafenib and quinacrine target anti-apoptotic protein Mcl-1: a poor prognostic marker in anaplastic thyroid cancer (ATC)

PURPOSE & EXPERIMENTAL DESIGN: Anaplastic thyroid cancer (ATC) comprises ~2% of all thyroid cancers and its median survival rate remains poor. It is responsible for more than one-third of thyroid cancer-related deaths. ATC is frequently resistant to conventional therapy and NFκB-signaling has be...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Clin Cancer Res
Asıl Yazarlar: Abdulghani, Junaid, Gokare, Prashanth, Gallant, Jean-Nicolas, Dicker, David, Whitcomb, Tiffany, Cooper, Timothy, Liao, Jiangang, Derr, Jonathan, Liu, Jing, Goldenberg, David, Finnberg, Niklas K., El-Deiry, Wafik S.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2016
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7524204/
https://ncbi.nlm.nih.gov/pubmed/27307592
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-15-2792
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller